Active, Not Recruiting
Lenvatinib and Everolimus in Treating Patients With Advanced, Unresectable Carcinoid Tumors
NCT03950609
- Conditions
- Advanced Carcinoid Tumor, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Digestive System Neuroendocrine Neoplasm, +16 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States